Medicine Press release



Eisai Completes Construction of Its New Injection/Research Building at Kawashima Industrial Park in Japan
Oct 04, 2022 15:44 JST
Eisai Co., Ltd. announced that, as part of the strategic investment towards the realization of its medium-term business plan "EWAY Future & Beyond", it has completed construction of the new injection/research building "Eisai Medicine Innovation Technology Solutions" ("EMITS") at the Kawashima Industrial Park located in Gifu Prefecture, Japan.
More info..


Olympus Launches THUNDERBEAT Energy Device for Open Surgery
Sep 30, 2022 10:00 JST
Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, today announced the release of the THUNDERBEAT(TM) Open Fine Jaw Type X surgical energy devices for open surgery.
More info..


Olympus Launches THUNDERBEAT Energy Device for Open Surgery
Sep 30, 2022 10:00 JST
Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, today announced the release of the THUNDERBEAT(TM) Open Fine Jaw Type X surgical energy devices for open surgery.
More info..


Olympus Launches THUNDERBEAT Energy Device for Open Surgery
Sep 30, 2022 10:00 JST
Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, today announced the release of the THUNDERBEAT(TM) Open Fine Jaw Type X surgical energy devices for open surgery.
More info..


Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint
Sep 28, 2022 14:15 JST
Eisai Co., Ltd. and Biogen Inc. announced positive topline results from Eisai's large global Phase 3 confirmatory Clarity AD clinical trial of lecanemab.
More info..


Eisai: Metoject Subcutaneous Injection Syringe (Methotrexate) Approved in Japan for Rheumatoid Arthritis
Sep 26, 2022 19:14 JST
Eisai Co., Ltd. and nippon medac Co., Ltd. today that they have obtained manufacturing and marketing approval from the Japanese Ministry of Health, Labour and Welfare for the indication of the anti-rheumatic agent "Metoject Subcutaneous Injection 7.5mg syringe 0.15mL, 10mg syringe 0.20mL, 12.5mg syringe 0.25mL and 15mg syringe 0.30mL" (methotrexate, "MTX") for the treatment of rheumatoid arthritis.
More info..


Fujitsu, Tohoku University embark on strategic alliance to realize 'Well-being Society'
Sep 26, 2022 11:18 JST
Fujitsu Limited and Tohoku University today announced the start of a strategic alliance to accelerate the shift towards preventive healthcare and the realization of a 'Well-being Society' in which no one will be left behind.
More info..


Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines
Sep 13, 2022 06:40 JST
PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, a Covid-19 vaccine brand it has developed since November 2021.
More info..


Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines
Sep 13, 2022 06:40 JST
PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, a Covid-19 vaccine brand it has developed since November 2021.
More info..


Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines
Sep 13, 2022 06:40 JST
PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, a Covid-19 vaccine brand it has developed since November 2021.
More info..